Ind-Swift Laboratories Limited Share Price and Company Fundamentals
Last traded: Last Friday at 9:59 AM
Ind-Swift Laboratories Limited, together with its subsidiaries, develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, Parkinson's disease, hyperparathyrodism, analgesic, aromatase inhibitor, nootropic, antidiarrhoeal/antiprotozoal, alcohol abstinence, antineoplastic, ADHD symptoms, anticancer, hypercholesterolemia, antimuscarinic, antimigraine, and thrombocytopenia. It also provides reference standards and impurities for acamprosate calcium, anastrozole, aripiprazole, atorvastatin calcium, azithromycin dihydrate, bexarotene, cinacalcet hydrochloride, clopidogrel bisulphate, clopidogrel hydrochloride, dapoxetine hydrochloride, donepezil hydrochloride, ezetimibe, fexofenadine hydrochloride, imatinib mesylate, ivabradine hydrochloride, ivabradine oxalate, letrozole, mecloxamine citrate, naratriptan hydrochloride, nateglinide, nitazoxanide, nitrosamine, pazopanib hydrochloride, quetiapine hemifumarate, raltegravir potassium, ropinirole hydrochloride, rosuvastatin calcium, saxagliptin monohydrate, silodosin, and temozolomide, as well as contract research and manufacturing services. The company exports its products. Ind-Swift Laboratories Limited was incorporated in 1995 and is based in Manimajra, India.
Key Metrics
PE ratio
3.98
PB ratio
0.84
Dividend yield
-
Beta
0.64
Market cap
₹11.90B
Enterprise value
₹7.22B
Company profile
| Industry / Sector | Drug Manufacturers - Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 1246 |
| Website | https://www.indswiftlabs.com |
| Mailing address | Shivalik Enclave SCO 850 NAC Manimajra 160101 India |
| Phone / Fax | 91 17 2506 1850 / 91 17 2273 0504 |
Dividends
Dividend yield
-
Dividend amount
₹-
Payout ratio
0.00%
5Y Avg. yield
-%
Ind-Swift Laboratories Limited paid ₹- dividend and the ex-dividend date was 20 Sep 2011.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.INDSWFTLAB dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Mar 2026, following are the company executives and directors listed on Ind-Swift Laboratories Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Navrattan R. Munjal | Chairman & MD | 73 | |
| Mr. Himanshu Jain BCom | Joint MD & Whole Time Director | 43 | |
| Mr. Gagan Aggarwal | Chief Financial Officer | ||
| Lalit Goyal | Vice President of Accounts | ||
| Mr. Pardeep Verma | VP of Corporate Affairs, Compliance Officer & Company Secretary | ||
| Mr. Rishav Mehta | Executive Director | 34 | |
| Mr. Sahil Munjal | Executive Director | 45 | |
| Anil Ratanlal Agrawal | Chief Operating Officer | ||
| Varun Chhabra | Senior Vice President of Marketing | ||
| Akashdeep Sharma | Vice President of HR |
Profitability and management effectiveness
Profit margin
41.86%
Operating margin
-3.09%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Ind-Swift Laboratories Limited is 11.90B and its enterprise value is 7.22B. The enterprise value to revenue ratio of INDSWFTLAB is 1.22. The enterprise value to EBITDA ratio of INDSWFTLAB is -14.02.
The INDSWFTLAB's stocks Beta value is 0.64 making it 36% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Ind-Swift Laboratories Limited (NSE:INDSWFTLAB) Frequently Asked Questions
1. What is Ind-Swift Laboratories Limited's Stock Symbol?
Ind-Swift Laboratories Limited trades on NSE under the ticker symbol "INDSWFTLAB".
2. What is Ind-Swift Laboratories Limited's stock price today?
One share of INDSWFTLAB stock can currently be purchased for approximately ₹137.2.
3. How can I contact Ind-Swift Laboratories Limited?
Ind-Swift Laboratories Limited's mailing address is Shivalik Enclave SCO 850 NAC Manimajra 160101 India. The company can be reached via phone at 91 17 2506 1850.
4. What is Ind-Swift Laboratories Limited's official website?
The official website of Ind-Swift Laboratories Limited is https://www.indswiftlabs.com.